Feb 29 |
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Q4 2023 Fulgent Genetics Inc Earnings Call
|
Feb 28 |
Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023
|
Feb 28 |
Fulgent Genetics Non-GAAP EPS of $0.28 beats by $0.57, revenue of $70.51M beats by $4.19M
|
Feb 28 |
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 27 |
Fulgent Genetics Q4 2023 Earnings Preview
|
Feb 21 |
Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
|
Feb 13 |
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
|
Feb 9 |
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
|